Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. N-(8-(2-hydroxybenzoyl)amino)caprylate
2. N-(8-(2-hydroxybenzoyl)amino)caprylate Sodium
3. N-snac
4. Snac Sodium
5. Sodium N-(8-(2-hydroxybenzoyl)amino)caprylate
1. 203787-91-1
2. Snac
3. Sodium 8-(2-hydroxybenzamido)octanoate
4. E414
5. Salcaprozate Sodium [usan]
6. Sodium;8-[(2-hydroxybenzoyl)amino]octanoate
7. Octanoic Acid, 8-[(2-hydroxybenzoyl)amino]-, Monosodium Salt
8. Salcaprozate (sodium)
9. Sodium,8-[(2-hydroxybenzoyl)amino]octanoate
10. 1ytw0422yu
11. Sodium 8-[(2-hydroxybenzoyl)amino]octanoate
12. E-414
13. Sodium 8-((2-hydroxybenzoyl)amino)octanoate
14. Salcaprozate Sodium (usan)
15. Octanoic Acid, 8-((2-hydroxybenzoyl)amino)-, Monosodium Salt
16. Sodium Salcaprozate
17. Unii-1ytw0422yu
18. Salcaprozic Acid, Sodium Salt
19. E 414
20. Salcaprozate Sodium, 99%
21. Salcaprozic Acid Sodium Salt
22. Schembl825599
23. Chembl2107027
24. Dtxsid50174306
25. Amy24031
26. Ex-a3434
27. Mfcd00952954
28. Sodium8-(2-hydroxybenzamido)octanoate
29. Ac-31357
30. As-65676
31. P414
32. Hy-114299
33. Cs-0081977
34. Ft-0696582
35. D05787
36. I10998
37. A879665
38. Q27253228
39. Sodium 8-[(2-hydroxyphenyl)formamido]octanoate
40. Octanoic Acid, 8-[(2-hydroxybenzoyl)amino]-, Sodium Salt
41. Sodium,8-[(2-hydroxybenzoyl)amino]octanoate;sodium 8-(2-hydroxybenzamido)octanoate
| Molecular Weight | 301.31 g/mol |
|---|---|
| Molecular Formula | C15H20NNaO4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 9 |
| Exact Mass | 301.12900240 g/mol |
| Monoisotopic Mass | 301.12900240 g/mol |
| Topological Polar Surface Area | 89.5 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 312 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Market Place
APIs
Reply
01 Apr 2024
Reply
30 Jul 2022
Reply
08 Jul 2022
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
ABOUT THIS PAGE
A Salcaprozate Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Salcaprozate Sodium, including repackagers and relabelers. The FDA regulates Salcaprozate Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Salcaprozate Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Salcaprozate Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Salcaprozate Sodium supplier is an individual or a company that provides Salcaprozate Sodium active pharmaceutical ingredient (API) or Salcaprozate Sodium finished formulations upon request. The Salcaprozate Sodium suppliers may include Salcaprozate Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Salcaprozate Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Salcaprozate Sodium DMF (Drug Master File) is a document detailing the whole manufacturing process of Salcaprozate Sodium active pharmaceutical ingredient (API) in detail. Different forms of Salcaprozate Sodium DMFs exist exist since differing nations have different regulations, such as Salcaprozate Sodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Salcaprozate Sodium DMF submitted to regulatory agencies in the US is known as a USDMF. Salcaprozate Sodium USDMF includes data on Salcaprozate Sodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Salcaprozate Sodium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Salcaprozate Sodium suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Salcaprozate Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Salcaprozate Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Salcaprozate Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Salcaprozate Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Salcaprozate Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Salcaprozate Sodium suppliers with NDC on PharmaCompass.
Salcaprozate Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Salcaprozate Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Salcaprozate Sodium GMP manufacturer or Salcaprozate Sodium GMP API supplier for your needs.
A Salcaprozate Sodium CoA (Certificate of Analysis) is a formal document that attests to Salcaprozate Sodium's compliance with Salcaprozate Sodium specifications and serves as a tool for batch-level quality control.
Salcaprozate Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Salcaprozate Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Salcaprozate Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Salcaprozate Sodium EP), Salcaprozate Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Salcaprozate Sodium USP).
LOOKING FOR A SUPPLIER?
Comment (6)
